Lilly and ImaginAb Announce Preclinical Immuno-Oncology Collaboration, no terms
October 13, 2015 at 07:01 AM EDT
Eli Lilly and Company (NYSE: LLY) and ImaginAb Inc. are pleased to announce a preclinical research collaboration to study potential ...
